Russo Partners

@russopartners

We partner with healthcare and biotechnology companies to navigate critical moments by communicating the science, strategy, and value behind their innovation.

New York City russopartnersllc.com Joined November 2008

1.4K Following 1.6K Followers 13K Posts

Latest posts 5

Pinned post

Russo Partners @russopartners Apr 9

The new Russo Partners website is live. Explore our Insights hub, the Russo Edge Podcast, and how we work across media, IR, digital, and strategy to translate complex science into clear stories. bit.ly/3WtK0Il

#Biotech #LifeSciences #Healthcare #PR

Russo Partners @russopartners 1d

Biotech companies often build themselves to win approval. Commercial success takes something different. Harris Kaplan joins @SolomonsWisdom on the Russo Edge to explain why.

▶️ Interview & video: russopartnersllc.com/insights/appro…
🎙️ Apple Podcasts: podcasts.apple.com/us/podcast/app…

#Biotech #DrugDevelopment

0:47

Russo Partners @russopartners 2d

What if patients could produce their own biologics? @BioCentury’s Danielle Golovin profiles Duracyte, a @RiceUniversity spinout building cell implants that secrete biologics in the body for up to a year. First trial expected in the first half of 2027.

biocentury.com/article/661149…

#Biotech #CellTherapy

Russo Partners @russopartners 4d

Spinal cord injury isn’t rare, but no two cases look alike. Former @US_FDA acting commissioner Dr. Janet Woodcock tells @PharmaPinkSheet the field needs rare-disease-style regulatory flexibility. insights.citeline.com/pink-sheet/r-a…

#SCI

Russo Partners @russopartners Oct 30

Spinal cord injury drugs may need a different kind of clinical trial. In @Citeline’s In Vivo, Bridget Silverman speaks with former @FDA chief Janet Woodcock on why the condition calls for more flexible, patient-centered endpoints.

insights.citeline.com/in-vivo/leader…

#SpinalCordInjury #FDA